CT-Guided Lipid-Lowering Therapy Leading to Functional Resolution of Ischemia

Le résumé fourni par la source

BACKGROUND: Aggressive lipid-lowering therapy may lead to regression of atherosclerosis; there are scarce data supporting such an approach for improving coronary physiological indexes. Serum low-density lipoprotein cholesterol is the primary target for lipid-lowering therapy. Computed tomography (CT)-derived assessments of plaque composition and coronary physiology are promising targets for individualized lipid-lowering strategies. CASE SUMMARY: in the left circumflex artery (0.93) and left anterior descending artery (0.88), and resolution of symptoms. DISCUSSION: This case demonstrates that CT-guided lipid-lowering therapy can reverse plaque burden and ischemia in a patient with a flow-limiting epicardial lesion. The therapeutic targets proposed here, addressing both morphological plaque characteristics and coronary physiology parameters, go beyond the traditional goal of lowering low-density lipoprotein cholesterol levels. Pharmacological strategy guided by precise plaque imaging and functional assessment requires confirmation in larger clinical studies. TAKE-HOME MESSAGE: CT-guided pharmacotherapy aimed at improving both plaque composition and epicardial coronary flow parameters may represent an alternative to uniform treatment strategies based on cholesterol levels.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.